| Mansi D Vaishnav, MD | |
|
2300 M St Nw Fl 8, Washington, DC 20037-1434 | |
| (202) 741-3270 | |
| Not Available |
| Full Name | Mansi D Vaishnav |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 9 Years |
| Location | 2300 M St Nw Fl 8, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689069437 | NPI | - | NPPES |
| 06502236 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 28833 (Mississippi) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | MD048613 (District Of Columbia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann Memorial City Hospital | Houston, TX | Hospital |
| Memorial Hermann Sugar Land Hospital | Sugar land, TX | Hospital |
| Memorial Hermann Hospital System | Houston, TX | Hospital |
| Memorial Hermann Katy Hospital | Katy, TX | Hospital |
| Memorial Hermann - Texas Medical Center | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Singleton Associates Pa | 6305731118 | 691 |
News Archive
Although the medical community has already accepted that colorectal cancer (CRC) screening is cost effective and saves lives, researchers have found that computed tomography colonography (CTC or virtual colonoscopy) not only identifies CRC but also doubles the yield of identifying significant early extracolonic (outside the colon) lesions, resulting in lives saved.
Fredericksburg Oncology is now accepting patients for a new clinical trial supported by the National Cancer Institute (NCI) to evaluate treatment for metastatic (advanced stage) melanoma. The current trial, designed at the Mayo Clinic, combines chemotherapy with targeted molecular agents in an effort to improve control of this difficult disease, reports Dr. Frederick C. Tucker, Jr., who heads this practice.
Yo-yo dieting, in which a person repeatedly loses and regains weight, may have a lasting negative impact on immune function, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that additional results from its Phase 3 trial (SYMMETRYSM) of elesclomol in combination with paclitaxel in metastatic melanoma was presented at the Perspectives in Melanoma XIII Conference by Steven O'Day, M.D., principal investigator and Chief of Research and Director of the Melanoma Program at the Angeles Clinic in Santa Monica, California.
› Verified 6 days ago
| Entity Name | Singleton Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538107875 PECOS PAC ID: 6305731118 Enrollment ID: O20040315000385 |
News Archive
Although the medical community has already accepted that colorectal cancer (CRC) screening is cost effective and saves lives, researchers have found that computed tomography colonography (CTC or virtual colonoscopy) not only identifies CRC but also doubles the yield of identifying significant early extracolonic (outside the colon) lesions, resulting in lives saved.
Fredericksburg Oncology is now accepting patients for a new clinical trial supported by the National Cancer Institute (NCI) to evaluate treatment for metastatic (advanced stage) melanoma. The current trial, designed at the Mayo Clinic, combines chemotherapy with targeted molecular agents in an effort to improve control of this difficult disease, reports Dr. Frederick C. Tucker, Jr., who heads this practice.
Yo-yo dieting, in which a person repeatedly loses and regains weight, may have a lasting negative impact on immune function, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that additional results from its Phase 3 trial (SYMMETRYSM) of elesclomol in combination with paclitaxel in metastatic melanoma was presented at the Perspectives in Melanoma XIII Conference by Steven O'Day, M.D., principal investigator and Chief of Research and Director of the Melanoma Program at the Angeles Clinic in Santa Monica, California.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mansi D Vaishnav, MD 2300 M St Nw Fl 8, Washington, DC 20037-1434 Ph: (202) 741-3270 | Mansi D Vaishnav, MD 2300 M St Nw Fl 8, Washington, DC 20037-1434 Ph: (202) 741-3270 |
News Archive
Although the medical community has already accepted that colorectal cancer (CRC) screening is cost effective and saves lives, researchers have found that computed tomography colonography (CTC or virtual colonoscopy) not only identifies CRC but also doubles the yield of identifying significant early extracolonic (outside the colon) lesions, resulting in lives saved.
Fredericksburg Oncology is now accepting patients for a new clinical trial supported by the National Cancer Institute (NCI) to evaluate treatment for metastatic (advanced stage) melanoma. The current trial, designed at the Mayo Clinic, combines chemotherapy with targeted molecular agents in an effort to improve control of this difficult disease, reports Dr. Frederick C. Tucker, Jr., who heads this practice.
Yo-yo dieting, in which a person repeatedly loses and regains weight, may have a lasting negative impact on immune function, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that additional results from its Phase 3 trial (SYMMETRYSM) of elesclomol in combination with paclitaxel in metastatic melanoma was presented at the Perspectives in Melanoma XIII Conference by Steven O'Day, M.D., principal investigator and Chief of Research and Director of the Melanoma Program at the Angeles Clinic in Santa Monica, California.
› Verified 6 days ago
Kimberly Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 301-902-1073 | |
Dr. Michael B Shvarts, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Joel Bowers, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1150 Varnum St Ne, Washington, DC 20017 Phone: 202-269-7000 | |
Krista Lyn Mcfarren, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3301 New Mexico Ave Nw, Suite 102, Washington, DC 20016 Phone: 202-966-0606 Fax: 202-244-6757 | |
Ranjith Vellody, MD Radiology Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Aaron Conard, Radiology Medicare: Not Enrolled in Medicare Practice Location: 5255 Loughboro Rd Nw, Washington, DC 20016 Phone: 240-366-7325 | |
Dr. Estelle Cooke-sampson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Ave Nw Ste 6101, Washington, DC 20060 Phone: 202-865-6679 Fax: 202-865-3138 |